State Policy

The Maryland House recently passed a bill – House Bill 631 – with the goal of “prohibiting a manufacturer or wholesale distributor…

In a city where crime rates are sky-high and illegal drugs are easily picked up on the street, on November 16, 2016, the City of…

As many of our readers know all too well, pharmaceutical companies are not permitted to discuss off-label, legal, alternative uses…

Last month, we wrote about the Connecticut APRN policy that is starting to come to fruition. As we noted, the dates of reporting…

Mere days before President Donald Trump was sworn into office, when any national action could (or would) be taken on drug pricing,…

We have previously written about Connecticut policy that was aimed at reporting payments from pharmaceutical and device…

Twenty states have announced that they have filed a lawsuit against generic-drug makers including Heritage Pharmaceuticals Inc.,…

In early October, Chicago mayor Rahm Emanuel announced a “series of efforts to combat heroin and opioid addiction throughout…

We recently wrote about Proposition 61 in California – a measure that would have required drug makers to provide large discounts…

California Governor Jerry Brown recently signed legislation allowing terminally ill patients in his state to have access to…